The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Prospective Analysis of High-Dose Interleukin-2 (HD IL-2) following PD-1 inhibitor therapy in patients with metastatic melanoma and renal cell carcinoma.
 
Elizabeth Iannotti Buchbinder
Employment - Merck (I)
Consulting or Advisory Role - Castle Biosciences; Immune Design
 
Janice P. Dutcher
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Merck; Novartis; Pfizer; Prometheus; TRACON Pharma
Speakers' Bureau - Novartis; Pfizer; Prometheus
Travel, Accommodations, Expenses - Merck; Novartis; Pfizer; Prometheus
 
Jessica C. Perritt
Employment - Prometheus
 
Joseph Clark
Honoraria - Bristol-Myers Squibb; Merck; Pfizer; Prometheus
Consulting or Advisory Role - Argos Therapeutics; Bayer; Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Merck; Prometheus
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Prometheus (Inst)
 
Shernan G. Holtan
No Relationships to Disclose
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; GreenPeptide; Roche
Research Funding - Merck (Inst); Prometheus (Inst)
 
Brendan D. Curti
Honoraria - Prometheus
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Agonox; Prometheus
 
Christopher D. Lao
No Relationships to Disclose
 
Howard Kaufman
Honoraria - Alkermes; Amgen; EMD Serono; Merck; Prometheus; Sanofi Pasteur
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb/Medarex
Travel, Accommodations, Expenses - Alkermes; EMD Serono; Sanofi
 
Mayer N. Fishman
No Relationships to Disclose
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)